Erika Ruiz-Garcia, Professor of Gastrointestinal Oncology and Head of the Translational Medicine Department at the National ...
Multiple Myeloma Symptoms, Treatment & Prognosis / blood cancer, Bone Lesions, Cancer in Younger Adults, Cassie ...
Leukemia in the Atomic Age / Acute Lymphoblastic Leukemia, ALL, cancer, Hematology, OncoDaily, OncoDailyBlood, Oncology, ...
Moving Beyond One-Size Fits All in HER2+ Breast Cancer Involves Understanding Trends. / Breast Cancer, cancer, HER2+ breast ...
Could Personalized Cancer Vaccines Shape the Future of Gynaecological Oncology? / cancer, esmo 2026, ESMO26, Georgina V. Long ...
New Strategies to Enhance Immunotherapy in HR+/HER2- Breast Cancer / Breast Cancer, cancer, esmo 2026, ESMO26, HR+/HER2− ...
NRG-GY020 Trial Finds No Added Benefit of Pembrolizumab With Adjuvant Radiotherapy in Early-Stage Endometrial Cancer / ...
Ivonescimab Plus Chemotherapy in Advanced Biliary Tract Cancer / Biliary tract cancer (BTC), cancer, cancer care, Cancer ...
Myeloma Paper of the Day, October 25th, Suggested by Robert Orlowski / Annemiek Broijl, cancer, Catharina H. M. J. van Elssen ...
Brilliant Discussion by Teresa Amaral at ESMO26 / cancer, ESMO, esmo 2026, ESMO26, Mario Balsa, Melanoma, OncoDaily, Oncology ...
On July 9, 2026, FDA approved isatuximab-irfc (Sarclisa Escena, Sanofi Aventis) for subcutaneous injection in multiple myeloma, extending to all currently approved IV isatuximab indications: In ...
VOLGA at ESMO 2026: Perioperative Durvalumab With or Without Tremelimumab Plus Enfortumab Vedotin in MIBC ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results